104 related articles for article (PubMed ID: 9808191)
21. The hu-PBL-SCID mouse model. Long-term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Cell Immunol; 1992 Feb; 139(2):468-77. PubMed ID: 1733515
[TBL] [Abstract][Full Text] [Related]
22. Enhanced engraftment of human peripheral blood lymphocytes into anti-murine interferon-gamma monoclonal antibody-treated C.B.-17-scid mice.
Shibata S; Asano T; Noguchi A; Kimura H; Ogura A; Naiki M; Doi K
Cell Immunol; 1998 Jan; 183(1):60-9. PubMed ID: 9578720
[TBL] [Abstract][Full Text] [Related]
23. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Eisenbeis CF; Grainger A; Fischer B; Baiocchi RA; Carrodeguas L; Roychowdhury S; Chen L; Banks AL; Davis T; Young D; Kelbick N; Stephens J; Byrd JC; Grever MR; Caligiuri MA; Porcu P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6101-10. PubMed ID: 15447996
[TBL] [Abstract][Full Text] [Related]
24. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
25. The use of the hu-PBL-SCID mouse model to study lymphocyte homing and responsiveness to recall antigens.
Lue C; Kiyono H; Fujihashi K; McGhee JR; Mestecky J
Reg Immunol; 1992; 4(2):86-90. PubMed ID: 1503891
[TBL] [Abstract][Full Text] [Related]
26. Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.
Beaman MH; Remington JS; Meyer DJ
Immunol Cell Biol; 2000 Dec; 78(6):608-15. PubMed ID: 11114971
[TBL] [Abstract][Full Text] [Related]
27. Specific immunosuppression of human anti-murine antibody responses in hu-PBL-SCID mice.
Bitoh S; Lang GM; Kierek-Jaszczuk D; Fujimoto S; Sehon AH
Hum Antibodies Hybridomas; 1993 Jul; 4(3):134-43. PubMed ID: 8357957
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.
Wu SJ; Hayes CG; Dubois DR; Windheuser MG; Kang YH; Watts DM; Sieckmann DG
Am J Trop Med Hyg; 1995 May; 52(5):468-76. PubMed ID: 7771614
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors.
Hoffmann-Fezer G; Kranz B; Gall C; Thierfelder S
Eur J Immunol; 1992 Dec; 22(12):3161-6. PubMed ID: 1359971
[TBL] [Abstract][Full Text] [Related]
30. The SCID mouse reaction to human peripheral blood mononuclear leukocyte engraftment. Neutrophil recruitment induced expression of a wide spectrum of murine cytokines and mouse leukopoiesis, including thymic differentiation.
Santini SM; Rizza P; Logozzi MA; Sestili P; Gherardi G; Lande R; Lapenta C; Belardelli F; Fais S
Transplantation; 1995 Dec; 60(11):1306-14. PubMed ID: 8525526
[TBL] [Abstract][Full Text] [Related]
31. Evidence for restricted diversity of antigen-specific human antibodies in immunized hu-PBL-SCID mice.
Bazin R; Chevrier MC; Delage R; Lemieux R
Hum Antibodies Hybridomas; 1996; 7(3):129-34. PubMed ID: 9057061
[TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of the heavy chain of antibodies that recognize the capsular polysaccharide of Neisseria meningitidis in hu-PBMC reconstituted SCID mice and in the immunized human donor.
Smithson SL; Srivastava N; Hutchins WA; Westerink MA
Mol Immunol; 1999 Feb; 36(2):113-24. PubMed ID: 10378683
[TBL] [Abstract][Full Text] [Related]
33. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
[TBL] [Abstract][Full Text] [Related]
34. A promising model of primary human immunization in human-scid mouse.
Bombil F; Kints JP; Scheiff JM; Bazin H; Latinne D
Immunobiology; 1996 Aug; 195(3):360-75. PubMed ID: 8877409
[TBL] [Abstract][Full Text] [Related]
35. T cell engraftment in lymphoid tissues of human peripheral blood lymphocyte reconstituted SCID mice with or without prior activation of cells.
Olive C; Cheung C; Falk MC
Immunol Cell Biol; 1998 Dec; 76(6):520-5. PubMed ID: 9893029
[TBL] [Abstract][Full Text] [Related]
36. Establishment of human IgE system in severe combined immunodeficient mice with peripheral blood mononuclear cells from asthmatic children.
Chiang BL; Chou CC; Ding HJ; Huang MS; Chen JM; Hsieh KH
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):69-76. PubMed ID: 7822666
[TBL] [Abstract][Full Text] [Related]
37. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection.
Aaberge IS; Michaelsen TE; Rolstad AK; Groeng EC; Solberg P; Løvik M
Infect Immun; 1992 Oct; 60(10):4146-53. PubMed ID: 1398925
[TBL] [Abstract][Full Text] [Related]
38. Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.
Duchosal MA; Eming SA; McConahey PJ; Dixon FJ
Am J Pathol; 1992 Nov; 141(5):1097-113. PubMed ID: 1332484
[TBL] [Abstract][Full Text] [Related]
39. Suppression of human anti-mouse idiotypic antibody responses in hu-PBL-SCID mice.
Bitoh S; Lang GM; Sehon AH
Hum Antibodies Hybridomas; 1993 Jul; 4(3):144-51. PubMed ID: 8357958
[TBL] [Abstract][Full Text] [Related]
40. A study on the engraftment and trafficking of bovine peripheral blood leukocytes in severe combined immunodeficient mice.
Greenwood JD; Croy BA
Vet Immunol Immunopathol; 1993 Sep; 38(1-2):21-44. PubMed ID: 8256436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]